Edward Holland, MD
Show Description +
Edward Holland, MD, sees a topical presbyopia-correcting solution as fulfilling a significant unmet need for his presbyopic patients who are looking for a solution that benefits their overall quality of life. For patients who have undergone previous refractive surgery, or, have presbyopia and are burdened by the need for reading glasses, a novel therapeutic option presents an attractive treatment to bolster your practice's offerings.
Posted: 11/23/2021
Edward Holland, MD
Edward Holland, MD, sees a topical presbyopia-correcting solution as fulfilling a significant unmet need for his presbyopic patients who are looking for a solution that benefits their overall quality of life. For patients who have undergone previous refractive surgery, or, have presbyopia and are burdened by the need for reading glasses, a novel therapeutic option presents an attractive treatment to bolster your practice's offerings.
Posted: 11/23/2021
About Orasis Pharmaceuticals
ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.
The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.
Visit us online: orasis-pharma.com
Follow Orasis Pharmaceuticals